Anemia

The FDA has approved Jesduvroq tablets for treatment of anemia in patients with chronic kidney disease who are on dialysis, according to a press release.

The ACG has developed a clinical guideline to aid physicians in the diagnosis and management of patients with gastrointestinal subepithelial lesions, which recently was published in The American Journal of Gastroenterology.

Pediatric patients with anemia and chronic kidney disease can alternate between maintenance erythropoiesis-stimulating agents and subcutaneous continuous erythropoietin receptor activators every 4 weeks, according to a study.

During short exposure and follow-up periods, patients on dialysis with higher hemoglobin concentrations were at a reduced risk for death, hospitalization and ED visits, according to data published in Kidney Medicine.

Weighing the potential benefits for two different kidney patient populations, a review board for the FDA voted 13-3 to approve use of the anemia drug daprodustat for patients with dialysis-dependent chronic kidney disease.

NASHVILLE, Tenn. — Patients who were hospitalized with bacterial pneumonia with co-existing iron deficiency anemia did not have worse outcomes, including mortality, septic shock, acute respiratory failure and cardiac arrest.

Anemia independently correlated with lower eGFR and an increased risk of end-stage kidney disease, cardiovascular disease, coronary heart disease, stroke, heart failure and death, according to recently published data.

Despite the severe pain and mortality risk associated with sickle cell anemia, few children undergo the recommended screening and treatment for this condition and its complications, according to a CDC report.

Causes of MI such as hypoxemia and anemia, also tied to oxygen supply-demand imbalance, may confer greater 1-year all-cause mortality risk in patients with type 2 MI vs. type 1 MI, researchers reported.